VALENCIA, Calif., April 28 /PRNewswire-FirstCall/ -- MannKind Corporation (NASDAQ:MNKD) will release its 2008 first quarter financial results on Monday, May 5, 2008 at 4:00 p.m. EDT.
Management of the Company will host a conference call to discuss the first quarter financial results, clinical progress and other Company developments at 5:00 p.m. EDT on Monday, May 5, 2008. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President and Chief Financial Officer, Matthew Pfeffer and Corporate Vice President and Chief Scientific Officer, Peter Richardson.
To participate in the live call by telephone, please dial (800) 857-0373 or (210) 839-8507. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com/.
A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (866) 457-6651 or (203) 369-1300. A replay will also be available on MannKind's website for fourteen days.
About MannKind Corporation MannKind Corporation (NASDAQ:MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in Phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com/. DATASOURCE: MannKind Corporation CONTACT: Matthew Pfeffer, Chief Financial Officer, MannKind Corporation, +1-661-295-4784, Web site: http://www.mannkindcorp.com/
|